CAK Capital Management »

Teva Pharmaceutical Industries shares owned by CAK Capital Management

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by CAK Capital Management from 13F filings

Historical chart of CAK Capital Management investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by CAK Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by CAK Capital Management

Quarter filed Position value Share count Share price at filing
2011-03-31 $6.4M 128k 50.17

More positions owned by CAK Capital Management

Apple (AAPL)
Google
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Danaher Corporation (DHR)
Suncor Energy (SU)
At&t (T)
Abbott Laboratories (ABT)
Market Vectors Gold Miners ETF
Goldman Sachs (GS)
Total (TTE)
Best Buy (BBY)
Bunge
Qualcomm (QCOM)
Carnival Corporation (CCL)

View all positions for CAK Capital Management

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Arrowstreet Capital, Limited Partnership
Sphera Funds Management

View all funds holding Teva Pharmaceutical Industries